Çocuk Asistanlarının HPV Bilgi ve Farkındalık Düzeyleri: Eğitim Öncesi ve Sonrası Bir Çalışma

Yıl 2025, Cilt: 15 Sayı: 5, 250 - 256, 30.09.2025

Asena Ünal , Ümmühan Çay , Özlem Özgür Gündeşlioğlu , Derya Alabaz

https://doi.org/10.16899/jcm.1730371

Öz

Amaç: Bu çalışmanın amacı, pediatristlerin HPV enfeksiyonu ve HPV aşısı hakkındaki bilgi düzeylerini, aşıya yönelik tutumlarını ve eğitim sonrası bilgi ve farkındalık düzeylerindeki de-ğişimi değerlendirmektir.
Gereç ve Yöntem: Bu çalışmaya 90 pediatri asistanı dahil edilmiştir. Araştırmacılar tarafından hazırlanan 41 maddelik bir anket katılımcılara uygulanmıştır. Katılımcılara, HPV enfeksiyonu ve aşısı hakkında bir ön anket yapılmış, ardından kapsamlı bir eğitim oturumu verilmiştir. Eği-timin ardından aynı anket tekrar uygulanmış ve eğitim öncesi ve sonrası bilgi düzeyleri karşı-laştırılmıştır.
Bulgular: Çalışmaya toplam 90 pediatri asistanı katılmıştır. Katılımcıların çoğu HPV’nin ser-vikal kansere neden olduğunu bilmesine rağmen, diğer kanser türleri hakkında sınırlı bilgiye sahipti. Eğitim sonrası katılımcıların bilgi düzeylerinde anlamlı bir artış gözlenmiştir. Aşı ile ilgili bilgi eksiklikleri giderilmiş ve katılımcıların büyük çoğunluğu aşılamayı desteklemiştir. Eğitim öncesinde HPV aşısının yapılması gereken yaş grupları ve aşı türleri konusunda bilgi eksiklikleri varken, eğitim sonrasında katılımcıların bu konularda doğru bilgiye sahip oldukları görülmüştür. Ayrıca, aşının yüksek maliyeti, aşının uygulanma sıklığını doğrudan etkileyen bir engel olarak ortaya çıkmıştır.
Sonuç: Bu çalışmanın bulguları, eğitimin pediatristlerin HPV ve HPV aşısı konusundaki bilgi düzeylerini artırmada etkili olduğunu göstermiştir. Çalışmamız, HPV ile mücadelede sürekli eğitimin gerekliliğini ve pediatristlerin bilgilerini güncel tutmalarının halk sağlığı açısından kri-tik önemini vurgulamaktadır.

Anahtar Kelimeler

Farkındalık , HPV (İnsan Papillomavirüsü) , bilgi , pediatri

Pediatric Residents’ HPV Knowledge and Awareness: A Pre-Post Training Study

Öz

Background/Aims: The aim of this study is to evaluate pediatricians' level of knowledge about HPV infection and the HPV vaccine, their attitudes toward the vaccine, and changes in their knowledge and awareness after education.
Methods: This study included 90 pediatric residents. A 41-item questionnaire prepared by the researchers was administered to the participants. The participants were given a pre-survey on HPV infection and the vaccine, followed by a comprehensive educational ses-sion. After the education, the same survey was administered again, and the knowledge levels before and after the education were compared.
Results: A total of 90 pediatric residents participated in the study. Although most participants knew that HPV causes cervical cancer, they had limited knowledge of other type of cancers. A significant increase in the participants' knowledge levels was observed after education. Knowledge gaps regarding the vaccine were also addressed, and the vast majority of partici-pants supported vaccination. Prior to the education, there were gaps in knowledge regarding the age groups for HPV vaccination and types of vaccines; however, after the education, par-ticipants had accurate information. Furthermore, the high cost of the vaccine emerged as a barrier directly influencing the frequency of vaccine administration.
Conclusions: The findings of our study demonstrated the effectiveness of training in improving pediatricians' knowledge levels regarding HPV and the vaccine. Our study emphasizes the need for continuous training in the fight against HPV and the critical importance of maintai-ning pediatricians' knowledge up to date for public health.

Anahtar Kelimeler

HPV (Human Papillomavirus) , knowledge , pediatrics , vaccines

Etik Beyan

Ethical approval for the study was obtained from theÇukurova University Clinical Research Et-hics Committee (Meeting number: 138, 03 Nov 2023).

Destekleyen Kurum

None

Kaynakça

• 1- Loris Y. Hwang, Anna-Barbara Moscicki. Human Papillomavirus. In: Sarah S Long, editor. Principles and Practice of Pediatric Infectious Diseases. 6th ed. Philadelphia: Elsevier; 2023.pp. 1119-23.
• 2- World Health Organization. Human papillomavirus and cervical cancer, https://www.who.int/news-room/fact-sheets/detail/human-papillomavirus-(hpv)-and-cervical-cancer (Accessed on January 10 2025).
• 3- Bruni L, Albero G, Serrano B, Mena M, Collado JJ, Gómez D, et al. ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in the World. Summary Report 10 March 2023. https://hpvcentre.net/statistics/reports/XWX.pdf (Accessed on January 10 2025).
• 4- Wei F, Georges D, Man I, Baussano I, Clifford GM. Causal attribution of human papillomavirus genotypes to invasive cervical cancer worldwide: a systematic analysis of the global literature. Lancet 2024;404:435.
• 5- Frazer IH. Interaction of human papillomaviruses with the host immune system: a well evolved relationship. Virology 2009;384:410-414.
• 6- Akgün Aktaş B, Toptaş T, Üreyen I, Doğan S, Uysal A. Obstetrician-gynecologists’ practice patterns regarding HPV testing in cervical cancer screening in Turkey. Turk J Obstet Gynecol. 2021 Mar 12;18(1):15-22.
• 7- Joura EA, Kjaer SK, Wheeler CM, et al. HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccine. Vaccine 2008;26:6844-51.
• 8- Winer RL, Hughes JP, Feng Q, et al. Condom use and the risk of genital human papillomavirus infection in young women. N Engl J Med 2006;354:2645-54.
• 9- Petrosky E, Bocchini JA Jr, Hariri S, et al. Centers for Disease Control and Prevention (CDC). Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep 2015;64:300-4.
• 10- Giuliano AR, Joura EA, Garland SM, et al. Nine-valent HPV vaccine efficacy against related diseases and definitive therapy: comparison with historic placebo population. Gynecol Oncol 2019;154:110-7.
• 11- Lei J, Ploner A, Elfström KM, et al. HPV Vaccination and the Risk of Invasive Cervical Cancer. N Engl J Med 2020;383:1340-48.
• 12- Dursun P, Senger SS, Arslan H, Kuşçu E, Ayhan A. Human papillomavirus (HPV) prevalence and types among Turkish women at a gynecology outpatient unit. BMC Infect Dis 2009;9:191.
• 13- Castle PE, Fetterman B, Akhtar I, et al. Age-appropriate use of human papillomavirus vaccines in the U.S. Gynecol Oncol 2009;114:365.
• 14- Ozsurekci Y, Karadag Oncel E, Bayhan C, et al. Knowledge and attitudes about human papillomaviruses and immunization among Turkish pediatricians. Asian Pac J Cancer Prev 2013;14:7325-7329.
• 15- Tolunay O, Celik U, Karaman SS, et al. Awareness and attitude relating to the human papilloma virus and its vaccines among pediatrics, obstetrics and gynecology specialists in Turkey. Asian Pac J Cancer Prev 2014;15:10723-10728.
• 16- Anfinan NM. Physician's knowledge and opinions on human papillomavirus vaccination: a cross-sectional study, Saudi Arabia. BMC Health Serv Res 2019;19:963.
• 17- Wong LP. Preventing cervical cancer through human papillomavirus vaccination: perspective from focus groups. J Low Genit Tract Dis 2009;13:85-93.
• 18- Jaspers L, Budiningsih S, Wolterbeek R, Henderson FC, Peters AA. Parental acceptance of human papillomavirus (HPV) vaccination in Indonesia: A cross-sectional study. Vaccine 2011;29:7785-93.
• 19- Ortashi O, Raheel H, Shalal M, Osman N. Awareness and knowledge about human papillomavirus infection and vaccination among women in UAE. Asian Pac J Cancer Prev 2013;14:6077-80.
• 20- Alsaad MA, Shamsuddin K, Fadzil F. Knowledge towards HPV infection and HPV vaccines among Syrian Mothers. Asian Pac J Cancer Prev 2012;13:879-83.
• 21- Brown B, Gabra MI, Pellman H. Reasons for acceptance or refusal of Human Papillomavirus Vaccine in a California pediatric practice. Papillomavirus Res 2017;3:42-45.
• 22- Kong WY, Oh NL, Kennedy KL, et al. Identifying Healthcare Professionals With Lower Human Papillomavirus (HPV) Vaccine Recommendation Quality: A Systematic Review. J Adolesc Health 2024;74:868-877.
• 23- Bakare D, Gobbo E, Akinsola KO, et al. Healthcare worker practices for HPV vaccine recommendation: A systematic review and meta-analysis. Hum Vaccin Immunother 2024;20:2402122.
• 24- Özkaya Parlakay A, Yiğit M, Gülhan B, Bedir T, Kanık Yüksek S. Evaluation of Opinions of Pediatrists in A Tertiary Healthcare Hospiatal About Meningococcal, Rotavirus, Human Papilloma Virus Vaccines and Incidence of Encountering Vaccine Refusal and Reasons of Vaccine Refusal. Turk J Pediatr Dis 2020;14: 264-267.
• 25- World Health Organization. Global HPV programme status, https://app.powerbi.com/view?r=eyJrIjoiNDIxZTFkZGUtMDQ1Ny00MDZkLThiZDktYWFlYTdkOGU2NDcwIiwidCI6ImY2MTBjMGI3LWJkMjQtNGIzOS04MTBiLTNkYzI4MGFmYjU5MCIsImMiOjh9 (Accessed on January 10 2025).